SCOPUS 정보 검색 플랫폼

Nature Reviews Neurology

Volumn 7, Issue 2, 2011, Pages 74-75

Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis

(1) Filippi, Massimo a

a SAN RAFFAELE HOSPITAL (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CLADRIBINE; COMPLEMENT FACTOR H; FINGOLIMOD; GADOLINIUM; HISTIDINE; INTERFERON BETA SERINE; PLACEBO; TYROSINE;

ARTICLE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EARLY DIAGNOSIS; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER; HUMAN; LYMPHOCYTOPENIA; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; CLADRIBINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PROPYLENE GLYCOLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPHINGOSINE;

EID: 79751490610 PISSN: 17594758 EISSN: 17594766 Source Type: Journal
DOI: 10.1038/nrneurol.2010.215 Document Type: Article

Times cited : (6)

References (10)

1
- 28544436950
- Diagnostic criteria for multiple sclerosis: 2005 Revisions to the mcDonald Criteria
- DOI 10.1002/ana.20703
- Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria . Ann. Neurol. 58, 840-846 (2005). (Pubitemid 41746873)
- (2005) Annals of Neurology , vol.58 , Issue.6 , pp. 840-846
- Polman, C.H.¹ Reingold, S.C.² Edan, G.³ Filippi, M.⁴ Hartung, H.-P.⁵ Kappos, L.⁶ Lublin, F.D.⁷ Metz, L.M.⁸ McFarland, H.F.⁹ O'Connor, P.W.¹⁰ Sandberg-Wollheim, M.¹¹ Thompson, A.J.¹² Weinshenker, B.G.¹³ Wolinsky, J.S.¹⁴

2
- 77951281003
- Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group
- Doggrell, S. a. Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group. Expert Opin. Pharmacother. 11, 1225-1230 (2010).
- (2010) Expert Opin. Pharmacother. , vol.11 , pp. 1225-1230
- Doggrell, S.A.¹

3
- 0034955141
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
- McDonald, w. i. et al. recommended diagnostic criteria for multiple sclerosis: guidelines from the international Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-127 (2001).
- (2001) Ann. Neurol. , vol.50 , pp. 121-127
- McDonald, W.I.¹

4
- 76349085858
- Mri criteria for MS in patients with clinically isolated syndromes
- Montalban, X. et al. Mri criteria for MS in patients with clinically isolated syndromes. Neurology 74, 427-434 (2010).
- (2010) Neurology , vol.74 , pp. 427-434
- Montalban, X.¹ Et, A.²

5
- 77952991177
- Complement regulator factor H as a serum biomarker of multiple sclerosis disease state
- ingram, G. et al. Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain 133, 1602-1611 (2010).
- (2010) Brain , vol.133 , pp. 1602-1611
- Ingram, G.¹

6
- 34147161297
- Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- DOI 10.1212/01.wnl.0000258545.73854.cf, PII 0000611420070327000006
- Goodin, D. S. et al. neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology assessment Subcommittee of the american academy of neurology. Neurology 68, 977-984 (2007). (Pubitemid 46569129)
- (2007) Neurology , vol.68 , Issue.13 , pp. 977-984
- Goodin, D.S.¹ Frohman, E.M.² Hurwitz, B.³ O'Connor, P.W.⁴ Oger, J.J.⁵ Reder, A.T.⁶ Stevens, J.C.⁷

7
- 77950876430
- Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis
- van der voort, L. F. et al. Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis. Arch. Neurol. 67, 402-407 (2010).
- (2010) Arch. Neurol. , vol.67 , pp. 402-407
- Van Der Voort, L.F.¹

8
- 76149093586
- A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
- Kappos, L. et al. a placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387-401 (2010).
- (2010) N. Engl. J. Med. , vol.362 , pp. 387-401
- Kappos, L.¹

9
- 76149083915
- A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis
- Giovannoni, G. et al. a placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N. Engl. J. Med. 362, 416-426 (2010).
- (2010) N. Engl. J. Med. , vol.362 , pp. 416-426
- Giovannoni, G.¹

10
- 76149140914
- Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
- Cohen, J. a. et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362, 402-415 (2010).
- (2010) N. Engl. J. Med. , vol.362 , pp. 402-415
- Cohen, J.A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.